| 1 |
33244584 | A phase II Japanese trial of fludarabine, cyclophosphamide and rituximab for previously untreated chronic lymphocytic leukemia. | 2021 Mar 3 |
1 |
| 2 |
26489498 | [Monoclonal Antibodies in the Treatment of Chronic Lymphocytic Leukemia in 2015]. | 2015 |
1 |
| 3 |
22269114 | Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignancies. | 2012 Jun |
1 |
| 4 |
23606931 | Safety and efficacy of ofatumumab in patients with fludarabine and alemtuzumab refractory chronic lymphocytic leukaemia. | 2012 Aug |
1 |
| 5 |
21246311 | Targeted IV busulfan and fludarabine followed by post-allogeneic hematopoietic cell transplantation rituximab demonstrate encouraging activity in CD20+ lymphoid malignancies without increased risk of infectious complications. | 2011 Feb |
1 |
| 6 |
21595596 | Ofatumumab in the treatment of low-grade non-Hodgkin's lymphomas and chronic lymphocytic leukemia. | 2011 May |
1 |
| 7 |
21856867 | Ofatumumab is active in patients with fludarabine-refractory CLL irrespective of prior rituximab: results from the phase 2 international study. | 2011 Nov 10 |
1 |
| 8 |
21918174 | rILYd4, a human CD59 inhibitor, enhances complement-dependent cytotoxicity of ofatumumab against rituximab-resistant B-cell lymphoma cells and chronic lymphocytic leukemia. | 2011 Nov 1 |
1 |
| 9 |
22287865 | Role of ofatumumab in treatment of chronic lymphocytic leukemia. | 2011 |
1 |
| 10 |
20194866 | Ofatumumab as single-agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia. | 2010 Apr 1 |
1 |
| 11 |
20425394 | New agents in chronic lymphocytic leukemia. | 2010 Jan |
1 |
| 12 |
20620977 | Monoclonal antibody therapy of chronic lymphocytic leukaemia. | 2010 Mar |
1 |
| 13 |
18006839 | Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine. | 2007 Nov 15 |
1 |
| 14 |
16430461 | Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-CD20 monoclonal antibody rituximab. | 2006 Feb |
1 |
| 15 |
14697987 | B-cell lymphoproliferative syndrome and peripheral blood CD20+ cells expansion after hematopoietic stem cell transplantation: association with fludarabine and anti-thymocyte globulin containing conditioning regimen. | 2003 Dec |
4 |
| 16 |
12270062 | Symptomatic Epstein-Barr virus reactivation in a patient with acute myeloid leukaemia and treatment with the monoclonal anti-CD20 antibody rituximab. | 2002 Jul |
1 |
| 17 |
10444162 | Cost-minimization analysis of CHOP, fludarabine and rituximab for the treatment of relapsed indolent B-cell non-Hodgkin's lymphoma in the U.K. | 1999 Jul |
1 |
| 18 |
10529513 | Rituximab (anti-CD20 monoclonal antibody) administration in a young patient with resistant B-prolymphocytic leukemia. | 1999 |
1 |
| 19 |
8599867 | Natural killer cell activity in chronic lymphocytic leukemia patients treated with fludarabine. | 1996 |
1 |